Comparing Yubo International Biotech (YBGJ) & Its Competitors

Profitability

This table compares Yubo International Biotech and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Yubo International Biotech	-274.96%	N/A	-121.41%
Yubo International Biotech Competitors	-299.60%	-764.44%	-27.12%

Risk and Volatility

Yubo International Biotech has a beta of 3.09, meaning that its stock price is 209% more volatile than the S&P 500. Comparatively, Yubo International Biotech’s competitors have a beta of 16.54, meaning that their average stock price is 1,554% more volatile than the S&P 500.

Earnings & Valuation

This table compares Yubo International Biotech and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Yubo International Biotech	$610,000.00	-$1.20 million	-8.10
Yubo International Biotech Competitors	$980.66 million	$79.50 million	9.98

Yubo International Biotech’s competitors have higher revenue and earnings than Yubo International Biotech. Yubo International Biotech is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

44.3% of shares of all “Electromedical equipment” companies are held by institutional investors. 56.5% of Yubo International Biotech shares are held by insiders. Comparatively, 15.3% of shares of all “Electromedical equipment” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Yubo International Biotech competitors beat Yubo International Biotech on 6 of the 9 factors compared.

About Yubo International Biotech

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.